Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Nov 5, 2020
Date Accepted: Jan 4, 2021
Date Submitted to PubMed: Jan 6, 2021

The final, peer-reviewed published version of this preprint can be found here:

Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic

Greene SK, McGough SF, Culp GM, Graf LE, Lipsitch M, Menzies NA, Kahn R

Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic

JMIR Public Health Surveill 2021;7(1):e25538

DOI: 10.2196/25538

PMID: 33406053

PMCID: 7812916

Nowcasting for Real-Time COVID-19 Tracking in New York City: Evaluation Study Using Reportable Disease Data, March–May 2020

  • Sharon K Greene; 
  • Sarah F McGough; 
  • Gretchen M Culp; 
  • Laura E Graf; 
  • Marc Lipsitch; 
  • Nicolas A Menzies; 
  • Rebecca Kahn

ABSTRACT

Background:

Nowcasting approaches enhance the utility of reportable disease data for trend monitoring by correcting for delays, but implementation details affect accuracy.

Objective:

To support real-time COVID-19 situational awareness, the New York City Department of Health and Mental Hygiene used nowcasting to account for testing and reporting delays. We conducted an evaluation to determine which implementation details would yield the most accurate estimated case counts.

Methods:

A time-correlated Bayesian approach called Nowcasting by Bayesian Smoothing (NobBS) was applied in real-time to linelists of reportable disease surveillance data, accounting for the delay from diagnosis to reporting and the shape of the epidemic curve. We retrospectively evaluated nowcasting performance for confirmed case counts among residents diagnosed during March–May 2020, a period when the median reporting delay was 2 days.

Results:

Nowcasts with a 2-week moving window and a negative binomial distribution had lower mean absolute error, lower relative root mean square error, and higher 95% prediction interval coverage than nowcasts conducted with a 3-week moving window or with a Poisson distribution. Nowcasts conducted toward the end of the week outperformed nowcasts performed earlier in the week, given fewer patients diagnosed on weekends and lack of day-of-week adjustments. When estimating case counts for weekdays only, metrics were similar across days the nowcasts were conducted, with Mondays having the lowest mean absolute error, of 183 cases in the context of an average daily weekday case count of 2,914.

Conclusions:

Nowcasting using NobBS can effectively support COVID-19 trend monitoring. Suppressing diagnoses on weekends, when fewer patients submitted specimens for testing, improved accuracy of estimated case counts. Nowcasting ensured that recent decreases in observed case counts were not overinterpreted as true declines and supported officials in anticipating the magnitude and timing of hospitalizations and deaths and allocating resources geographically.


 Citation

Please cite as:

Greene SK, McGough SF, Culp GM, Graf LE, Lipsitch M, Menzies NA, Kahn R

Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic

JMIR Public Health Surveill 2021;7(1):e25538

DOI: 10.2196/25538

PMID: 33406053

PMCID: 7812916

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.